NCT04587128
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04587128
Title Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Wisconsin, Madison
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA